PureHealth and Dell Technologies team up to utilize generative AI in care delivery

UAE – PureHealth has joined forces with Dell Technologies to utilize generative artificial intelligence (AI) across medical care services in the United Arab Emirates.

Under the new partnership, PureHealth will work closely with Dell Technologies to utilize generative AI to enhance the health ecosystem in the Emirate of Abu Dhabi.

The collaboration will harness the collective resources and technologies of both companies to improve health outcomes in the region.

In a joint release from PureHealth and Dell Technologies, Walid Yehia, General Manager, UAE at Dell Technologies, said: “GenAI continues to drive meaningful conversations and propel tangible progress across industries. We are using our position as the world’s broadest GenAI infrastructure portfolio provider to help PureHealth deliver critical services to citizens.”

In particular, PureHealth and Dell Technologies will combine specific capabilities to ensure access to leading medical solutions and services and accelerate long-term preparedness and agility.

Junaid Khan, the Chief Technology Officer at PureHealth, and Walid Yehia, the UAE’s General Manager of Dell Technologies, presided over the signing ceremony between the two organizations.

The signing ceremony was witnessed by Michael Dell, Founder, Chairman, and Chief Executive Officer of Dell Technologies, and Farhan Malik, Founder, Managing Director, and CEO of PureHealth.

In his address, Junaid Khan, the Chief Technology Officer at PureHealth, said: “This collaboration signifies our unwavering commitment to advancing the future of healthcare by harnessing the rapidly increasing computing power and normalizing GenAI-based outcomes.”

With Dell’s innovative solutions, PureHealth aims to positively impact the well-being of communities by offering better patient experiences through intelligent healthcare decision-making and advancing health research.

PureHealth owns a robust and expansive network encompassing hospitals, clinics, numerous diagnostic centers, insurance solutions, pharmacies, health tech, and procurement services.

The organization is actively reshaping the future of healthcare through a strategic fusion of technology and data, while also pioneering innovative GenAI-driven solutions.

Commenting on the transformative journey with Dell, Junaid Khan stated: “By integrating GenAI, we are poised to revolutionize the industry, improve health outcomes, and fortify our healthcare system’s readiness for the future.”

According to key statistics from Acumen Research and Consulting, the global AI in healthcare market size was valued at US$11.2 billion in 2022.

The AI in healthcare market is a pivotal component of the modern medical industry, focusing on the development, integration, and application of AI technologies for advanced healthcare solutions.

This market is witnessing exponential growth due to the rising need to reduce healthcare costs, advancements in computing power, and the development of innovative AI-driven tools.

It is estimated to achieve a market size of US$27.5 billion by 2032; growing at a compound annual growth rate (CAGR) of 44.0%.

With increasing investments in this market, medical providers, hospitals, and pharmaceutical and biotechnology companies are projected to take a significant turn in how they operate.

It is worth mentioning that Dell’s GenAI brings with it a multitude of advantages in healthcare, especially in analyzing extensive medical data and offering personalized treatment plans based on individual patient profiles.

“Our efforts align seamlessly with our vision of extending human health span. GenAI is a powerful tool and will be incorporated in our digital transformation where we aim to take healthcare to the cloud,” outlined Junaid Khan.

GenAI can also improve medical imaging accuracy, aid in predictive analytics for disease outbreaks, expedite drug discovery, and in turn, contribute to a more efficient and patient-centered healthcare landscape.

Moreover, the latest collaborative endeavor is crucial to the growth of PureHealth as it is looking to maintain its position as a trailblazer in the pursuit of longevity science and the transformation of healthcare systems.

It is poised to further solidify PureHealth’s position as a global healthcare provider following the recent milestone acquisitions of Ardent Health Services and Circle Health Group.

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.